CYPHERPUNK TECHNOLOGIES INC. Total Liabilities
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Total Liabilities of $3.65 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-12
- 2026-06-30: Liabilities $3.65M.
- 2026-03-31: Liabilities $3.00M.
- 2025-12-31: Liabilities $9.68M.
- 2025-09-30: Liabilities $8.70M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $3.65M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.68M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $8.70M 10-Q · filed 2025-11-12 |
| 2024-12-31 | $14.08M 10-K · filed 2026-03-16 |
| 2024-09-30 | $16.09M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $15.64M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $10.59M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $12.68M 10-Q · filed 2024-11-13 |
| 2023-09-30 | $11.04M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $11.80M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.50M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.49M 10-K · filed 2024-03-18 |
| 2022-09-30 | $12.09M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.88M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $7.34M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $10.02M 10-K · filed 2023-03-24 |
| 2021-09-30 | $11.26M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.06M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $7.43M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $7.72M 10-K · filed 2022-03-11 |
| 2020-09-30 | $7.41M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $7.94M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.78M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $9.20M 10-K · filed 2021-03-12 |
| 2019-09-30 | $8.58M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $9.20M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $9.02M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $9.90M 10-K · filed 2020-03-16 |
| 2018-09-30 | $20.50M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $22.27M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $22.56M 10-Q/A · filed 2018-08-08 |
| 2017-12-31 | $17.95M 10-K · filed 2019-04-01 |
| 2016-12-31 | $36.16M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |